Abstract:Macrocyclic compounds, characterized by cyclic structures, often originate from either modified forms of unicyclic canonical molecules or natural products. Within the field of medicinal chemistry, there has been a growing fascination with drug-like macrocycles in recent years, primarily due to compelling evidence indicating that macrocyclization can significantly influence both the biological and physiochemical properties, as well as the selectivity, when compared to their acyclic counterparts. The approval of contemporary pharmaceutical agents like Lorlatinib underscore the notable clinical relevance of drug-like macrocycles. Nonetheless, the synthesis of these drug-like macrocycles poses substantial challenges, primarily stemming from the complexity of ring-closing reactions, which are inherently dependent on the size and geometry of the bridging linker, impacting overall yields. Nevertheless, macrocycles offer a promising avenue for expanding the synthetic toolkit in medicinal chemistry, enabling the creation of bioactive compounds. To shed light on the subject, we delve into the clinical prowess of established macrocyclic drugs, spanning various therapeutic areas, including oncology, and infectious diseases. Case studies of clinically approved macrocyclic agents illustrate their profound impact on patient care and disease management. As we embark on this journey through the world of macrocyclic pharmaceuticals, we aim to provide a comprehensive overview of their synthesis and clinical applications, shedding light on the pivotal role they play in modern medicine.

Progress in the Research of Bioactivities of Plant-Derived Macrocyclic Diterpe-Noid Compounds

An Insight into the Medicinal Chemistry Perspective of Macrocyclic Derivatives with Antitumor Activity: A Systematic Review

Advances in the Structures, Pharmacological Activities, and Biosynthesis of Plant Diterpenoids

Recent progress on triterpenoid derivatives and their anticancer potential

Recent Advances on Macrocyclic Trichothecenes, Their Bioactivities and Biosynthetic Pathway

Recent progress and new perspectives for diterpenoid biosynthesis in medicinal plants

Macrocyclic Compounds For Drug And Gene Delivery In Immune-Modulating Therapy

Recent Advances of Natural Pentacyclic Triterpenoids as Bioactive Delivery System for Synergetic Biological Applications

Highly anticipated natural diterpenoids as an important source of new drugs in 2013–2023

Exploring the synthetic approaches and clinical prowess of established macrocyclic pharmaceuticals

Exploring And Exploiting Plant Cyclic Peptides For Drug Discovery And Development

Natural Product Triterpenoids and Their Semi-Synthetic Derivatives with Potential Anticancer Activity

Recent Progress on the Total Syntheses of Macrocyclic Diamine Alkaloids

Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery

Research progress on plant‐derived cardenolides(2010–2023)

Recent Progress on the Identification of Phenanthrene Derivatives in Traditional Chinese Medicine and Their Biological Activities

Recent Progresses on Pentacyclic Triterpene-Based Antiviral Agents

Terpenoids: natural products for cancer therapy

Progress on Biotransformation of Plant Antitumor Drugs

Recent Advances in Grayanane Diterpenes: Isolation, Structural Diversity, and Bioactivities from Ericaceae Family (2018–2024)

Lead/Drug Discovery from Natural Resources